CoChat

New roles for Smad signaling and phosphatidic acid in the regulation of skeletal muscle mass

Open access
Goodman, Craig A., Hornberger, Troy A. · 2014 · F1000Prime Reports

The DOI matches its Crossref record; 85 of the 85 references it cites were found in a registry or an index.

Abstract

Skeletal muscle is essential for normal bodily function and the loss of skeletal muscle (i.e. muscle atrophy/wasting) can have a major impact on mobility, whole-body metabolism, disease resistance, and quality of life. Thus, there is a clear need for the development of therapies that can prevent the loss, or increase, of skeletal muscle mass. However, in order to develop such therapies, we will first have to develop a thorough understanding of the molecular mechanisms that regulate muscle mass. Fortunately, our knowledge is rapidly advancing, and in this review, we will summarize recent studies that have expanded our understanding of the roles that Smad signaling and the synthesis of phosphatidic acid play in the regulation of skeletal muscle mass.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.12703/p6-20

Cites

85 of 85 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1. A general overview of recent findings related to Smad signaling and the synthesis of phosphatidic acid in the regulation of skeletal muscle mass Increases in transforming growth factor-beta (TGFβ), activins, and some growth and differentiation factors (GDFs), such as myostatin, lead to receptor-mediated phosphorylation of Smads 2 and 3, whereas increases in bone morphogenic proteins (BMPs) and other GDFs result in increased Smad 1, 5, and 8 phosphorylation. Phosphorylated Smads 2/3 compete with phosphorylated Smads 1/5/8 for binding to Smad4 before entering the nucleus to regulate gene transcription. Increased Smad2/3/4 signaling inhibits Akt/mTORC1 signaling and activates the expression of ubiquitin proteasome E3 ligases, atrogin-1 and muscle RING-finger protein-1 (MuRF1), ultimately leading to a decrease in protein synthesis and increased protein degradation. Increased Smad1/5/8/4 signaling activates Akt/mechanistic target of rapamycin complex 1 (mTORC1) signaling and represses the histone deacetylase 4 (HDAC4)/myogenin-mediated activation of E3 ligases (including MUSA1) under atrophic conditions, such as denervation. The net balance between Smad2/3/4 and Smad1/5/8/4 signaling appears to play a major role in determining skeletal muscle mass. The enzyme phospholipase D1 (PLD1) synthesizes PA, and PLD1 overexpression activates mTORC1 signaling and represses the expression of the E3 ligases, atrogin-1 and MuRF1. The zeta isoform of diacylglycerol kinase (DGKζ) also synthesizes PA and is required for a mechanically induced increase in PA and the subsequent activation of mTORC1. See text (“Bone morphogenic protein-induced Smad1/5/8 signaling and the regulation of skeletal muscle mass” section) for a more detailed explanation of these molecular signaling mechanisms.
Figure 1. A general overview of recent findings related to Smad signaling and the synthesis of phosphatidic acid in the regulation of skeletal muscle mass Increases in transforming growth factor-beta (TGFβ), activins, and some growth and differentiation factors (GDFs), such as myostatin, lead to receptor-mediated phosphorylation of Smads 2 and 3, whereas increases in bone morphogenic proteins (BMPs) and other GDFs result in increased Smad 1, 5, and 8 phosphorylation. Phosphorylated Smads 2/3 compete with phosphorylated Smads 1/5/8 for binding to Smad4 before entering the nucleus to regulate gene transcription. Increased Smad2/3/4 signaling inhibits Akt/mTORC1 signaling and activates the expression of ubiquitin proteasome E3 ligases, atrogin-1 and muscle RING-finger protein-1 (MuRF1), ultimately leading to a decrease in protein synthesis and increased protein degradation. Increased Smad1/5/8/4 signaling activates Akt/mechanistic target of rapamycin complex 1 (mTORC1) signaling and represses the histone deacetylase 4 (HDAC4)/myogenin-mediated activation of E3 ligases (including MUSA1) under atrophic conditions, such as denervation. The net balance between Smad2/3/4 and Smad1/5/8/4 signaling appears to play a major role in determining skeletal muscle mass. The enzyme phospholipase D1 (PLD1) synthesizes PA, and PLD1 overexpression activates mTORC1 signaling and represses the expression of the E3 ligases, atrogin-1 and MuRF1. The zeta isoform of diacylglycerol kinase (DGKζ) also synthesizes PA and is required for a mechanically induced increase in PA and the subsequent activation of mTORC1. See text (“Bone morphogenic protein-induced Smad1/5/8 signaling and the regulation of skeletal muscle mass” section) for a more detailed explanation of these molecular signaling mechanisms.CC BY-NC · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Show all 85 references

Research works printed but not linked: 1

  1. [79]O'Neil TK Duffy LR Frey JW Hornberger TA The role of phosphoinositide 3-kinase and phosphatidic acid in the regulation of mammalian target of rapamycin following eccentric contractions J Physiol (Lond) 2009 587 3691 701 10.1113/jphysiol.2009.173609 19470781 PMC2742291 · DOI · Paper page

Cited by

See all 30

Metadata

Authors
Goodman, C. A., & Hornberger, T. A.
Affiliations
University of Wisconsin–Madison (US)
Corresponding author
Hornberger, Troy A.
Venue
F1000Prime Reports
Published
2014-04-01
Volume
6
Pages
20-20
ISSN
2051-7599 (ISSN-L)
OpenAlex
W2095126612
Cited by
30
References
85
Citations by year
2026: 4 · 2025: 3 · 2024: 4 · 2023: 3 · 2022: 3 · 2021: 1 · 2020: 2 · 2019: 1 · 2018: 1 · 2017: 3 · 2016: 1 · 2015: 4
FWCI
0.25
Type
journal article
Language
en
Open access
Locations
  • F1000Prime Reports (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • Minerva Access (University of Melbourne) (submittedVersion, cc-by)
  • Victoria University Research Repository (Victoria University) (submittedVersion, cc-by)
Funders
  • National Institutes of Health (AR057347)
  • National Institute of Arthritis and Musculoskeletal and Skin Diseases (R21AR063256, R01AR057347)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
  • Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
Keywords
Smad signaling, phosphatidic acid, skeletal muscle mass, muscle atrophy, muscle mass regulation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: New roles for Smad signaling and phosphatidic acid in the regulation of skeletal muscle mass. https://app.cochat.ai/papers/10.12703/p6-20
The paper
Goodman, C. A., & Hornberger, T. A. (2014). New roles for Smad signaling and phosphatidic acid in the regulation of skeletal muscle mass. F1000Prime Reports. https://doi.org/10.12703/p6-20

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.